CSA Medical Advances RejuvenAir System for Chronic Bronchitis Treatment with FDA Submission CSA Medical has submitted a Premarket Approval application for its RejuvenAir System, aimed at treating chronic bronchitis in COPD patients, marking a significant milestone.

CSA Medical Advances RejuvenAir System for Chronic Bronchitis Treatment with FDA Submission #USA #Boston #Chronic_Bronchitis #RejuvenAir #CSA_Medical

Long-Term Guaifenesin Study Shows Significant Benefits for Stable Chronic Bronchitis Patients A recent long-term study highlights the effectiveness of extended-release Guaifenesin for chronic bronchitis, demonstrating significant symptom relief and improved quality of life.

Long-Term Guaifenesin Study Shows Significant Benefits for Stable Chronic Bronchitis Patients #USA #Mucinex #Parsippany #Guaifenesin #Chronic_Bronchitis